Azilect and Hospitalisation - a phase IV clinical study of FDA data

Summary:

Hospitalisation is reported as a side effect among people who take Azilect (rasagiline mesylate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Nuplazid, and have Hallucinations.

The phase IV clinical study analyzes which people have Hospitalisation when taking Azilect. It is created by eHealthMe based on reports of 8,121 people who have side effects when taking Azilect from the FDA, and is updated regularly.

What is Azilect?

Azilect has active ingredients of rasagiline mesylate. It is often used in parkinson's disease. eHealthMe is studying from 8,622 Azilect users. Check the latest studies of Azilect.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,716 drugs and 1,133 conditions by eHealthMe. Check the latest studies of Hospitalisation.

On Jul, 16, 2026

8,121 people reported to have side effects when taking Azilect.
Among them, 52 people (0.64%) have Hospitalisation.

Among these 52 people:

How long have people been on Azilect when they have Hospitalisation? *

What is the gender of people who have Hospitalisation when taking Azilect? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Hospitalisation when taking Azilect? *

What are other drugs people take besides Azilect? *

What are other side effects people have besides Hospitalisation? *

Hallucinations (sensations that appear real but are created by your mind): 10 people, 19.23%
Dyskinesia (abnormality or impairment of voluntary movement): 9 people, 17.31%
Weakness: 8 people, 15.38%
Device Dislocation: 8 people, 15.38%
General Physical Health Deterioration (weak health status): 7 people, 13.46%
Fall: 7 people, 13.46%
Abnormal Behavior: 6 people, 11.54%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 11.54%
Fatigue (feeling of tiredness): 6 people, 11.54%
Drowsiness: 6 people, 11.54%

What are the existing conditions these people have? *

Hallucinations (sensations that appear real but are created by your mind): 5 people, 9.62%
Delusion (a false belief or opinion): 4 people, 7.69%
Pain: 2 people, 3.85%
Enlarged Prostate: 2 people, 3.85%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 3.85%
Sedation: 1 person, 1.92%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 1.92%
High Blood Pressure: 1 person, 1.92%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 1.92%
Disturbance In Attention: 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Azilect and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azilect:

Azilect (8,622 reports)

Hospitalisation treatments and more:

Hospitalisation (143,651 reports)

Browse all side effects of Azilect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hospitalisation:

Hospitalisation (1,716 drugs)

Browse all the conditions that are associated with Hospitalisation:

Hospitalisation (1,133 conditions)

Related publications that referenced our studies

Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on rasagiline mesylate (the active ingredients of Azilect) and Azilect (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.